Results 261 to 270 of about 928,403 (288)

Chiroptical Properties of Symmetric Double, Triple, and Multiple Helicenes

Chemical Reviews, 2021
Tadashi Mori
exaly  

Pathogenesis of Triple-Negative Breast Cancer

Annual Review of Pathology: Mechanisms of Disease, 2022
Fatemeh Derakhshan, Jorge S Reis-Filho
exaly  

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Lancet, The, 2020
Javier Cortes, David W Cescon, Hope S Rugo   +2 more
exaly  

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

New England Journal of Medicine, 2022
Javier Cortes, Lajos Pusztai, Sherko Kümmel   +2 more
exaly  

Pembrolizumab for Early Triple-Negative Breast Cancer

New England Journal of Medicine, 2020
Javier Cortes, Lajos Pusztai, Sherko Kümmel   +2 more
exaly  

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Nature Reviews Clinical Oncology, 2016
Eapm Working Group For Oncology Clinical Research, Melinda E Sanders, Luca Gianni   +2 more
exaly  

Triple-negative breast cancer: disease entity or title of convenience?

Nature Reviews Clinical Oncology, 2010
Lisa A Carey, Giuseppe Viale, David A Cameron   +2 more
exaly  

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies

Cancer Cell, 2019
Yi-Zhou Jiang, Chen Suo, Xin Hu
exaly  

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

Lancet, The, 2017
Carsten Denkert, Andrew N J Tutt
exaly  

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Cell, 2018
Charissa R Kim, Johan Hartman, Nicola Crosetto   +2 more
exaly